BioVie Inc. Repayments of Short-term Debt
BioVie Inc. (BIVI) reported Repayments of Short-term Debt of $14.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2018-11-14
- BioVie Inc. repayments of short-term debt for the quarter ending 2018-09-30 was $14.00K, a 44.00% decline year-over-year.
- BioVie Inc. repayments of short-term debt for the quarter ending 2017-09-30 was $25.00K.
- BioVie Inc. repayments of short-term debt for fiscal 2018 was $35.00K.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 12 month |
|---|---|---|
| 2018-09-30 | $14.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $35.00K 10-K · filed 2018-10-05 | |
| 2017-09-30 | $25.00K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |